Publications by authors named "B Canaud"

In hemodialysis (HD), complement activation, bioincompatibility, and inflammation are intricately intertwined. In the 1970s, as HD became a routine therapy, the observation of complement pathway activation and transient leukopenia by cellulosic dialysis membranes triggered the bioincompatibility debate and its clinical relevance. Extensive deliberations have covered definitions, assessment markers, scope, and long-term clinical consequences of membrane-dependent bioincompatibility reactions.

View Article and Find Full Text PDF

The nonlinear evolution of bubble and spike fronts growing through the generalized Rayleigh-Taylor instability are studied by numerical simulations and by solving an extension of Alon's [Phys. Rev. E 48, 1008 (1993)2470-004510.

View Article and Find Full Text PDF
Article Synopsis
  • Cardiovascular diseases are the leading cause of illness and death in chronic kidney disease patients, with a study analyzing the impact of coronary artery calcifications (CAC) and cardiovascular biomarkers on major adverse cardiovascular events and deaths.
  • The study involved 425 non-dialysis CKD patients who underwent scans for CAC scoring and measurement of various cardiovascular risk biomarkers, with follow-up lasting an average of about 3.6 years.
  • Findings indicate that high CAC levels significantly increase the risk of major adverse cardiovascular events, especially when combined with certain inflammatory and metabolic conditions, suggesting that managing inflammation and improving mineral metabolism could be key strategies for reducing cardiovascular risk in these patients.
View Article and Find Full Text PDF
Article Synopsis
  • * Results indicated that 61% of patient-months involved some fluid overload, which significantly increased the risk of death, especially with severe overload (hazard ratio up to 3.42).
  • * It was concluded that even mild fluid overload elevates mortality risks in hemodialysis patients, highlighting the need for more research into effective fluid management strategies.
View Article and Find Full Text PDF

Background: High-dose haemodiafiltration has been shown, in a randomised clinical trial, to result in a 23% lower risk of mortality for patients with kidney failure when compared with conventional high-flux haemodialysis. Nevertheless, whether treatment effects differ across subgroups, whether a dose-response relationship with convection volume exists, and the effects on cause-specific mortality remain unclear. The aim of this individual patient data meta-analysis was to compare the effects of haemodiafiltration and standard haemodialysis on all-cause and cause-specific mortality.

View Article and Find Full Text PDF